Phenylbutyrate and Valganciclovir in Treating Patients With Relapsed or Refractory Epstein-Barr Virus-Positive Cancer
Conditions
- Gastric Cancer
- Head and Neck Cancer
- Lymphoma
- Lymphoproliferative Disorder
Interventions
- DRUG: oral sodium phenylbutyrate
- DRUG: valganciclovir
- GENETIC: polymerase chain reaction
- GENETIC: protein expression analysis
- PROCEDURE: biopsy
Sponsor
University of California, San Diego
Collaborators